2022 American Transplant Congress

Sunday, June 5, 2022

4:30pm-4:40pm

Development and Validation of a Kidney Transplant-Specific Measure of Treatment Burden

E. Lorenz¹, T. Petterson¹, I. Zaniletti¹, K. Lackore¹, B. Johnson¹, M. Mai², S. Nair³, A. Bentall¹, K. Yost¹, D. Eton¹

Kidney Psychosocial  •  Hynes Ballroom A

4:30pm-4:40pm

Early Clinical Experience With Nirmatrelvir/ritonavir For Treatment Of Covid-19 In Solid Organ Transplant Recipients

D. Salerno¹, D. Jennings², N. Lange³, D. Kovac¹, T. Shertel¹, J. Chen⁴, J. Hedvat⁵, J. Scheffert¹, R. S. Brown⁶, M. Pereira⁷

Late Breaking: Clinical  •  Hynes Room 313

4:30pm-4:40pm

First-in-Human Clinical-Grade Porcine Kidney Xenotransplant

J. E. Locke¹, B. Orandi¹, V. Kumar¹, J. Houp¹, D. Anderson¹, V. Hauptfeld¹, D. Martin², C. Killian¹, S. Macedon¹, N. Budd¹, K. Stegner¹, A. Dandro³, M. Kokkinaki³, K. Kuravi³, R. Reed⁴, H. Fatima¹, G. Baker¹, J. Perry¹, E. Bryant¹, M. Cheung¹, E. Erman¹, K. Kraebber¹, T. Gamblin¹, L. Guy¹, D. Ayares³, P. Porrett¹

Xenotransplantation  •  Hynes Room 302

4:30pm-4:40pm

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients

T. S. Mahmoud¹, J. Yagan¹, A. Hasan², O. Gheith¹, M. Mostafa¹, S. Rida¹, N. El-Serwy¹, M. Shaker¹, M. Khalid¹, P. Nair¹, T. Alotaibi¹

Kidney: Cardiovascular and Metabolic Complications I  •  Hynes Veterans Auditorium

4:30pm-4:40pm

Post-Kidney Transplant Valacyclovir or Valganciclovir for EBV Prophylaxis: A Randomized Controlled Trial

P. S. Verghese¹, A. Matas², S. Chinnakotla², M. Evans³, H. Balfour Jr⁴

Cytomegalovirus and other Herpes Viruses  •  Hynes Ballroom B

4:30pm-4:40pm

Role of Circulating Tumour Cells in the Management of the Liver Transplant Patient with Hepatocellular Carcinoma

F. Villalba¹, F. Alconchel², L. Sáenz³, M. Sánchez-Lorencio¹, D. Ferreras², P. Cascales², F. Sánchez-Bueno², R. Robles², P. Ramírez²

Hepatocellular Carcinoma and Other Malignancies  •  Hynes Room 312

4:30pm-4:40pm

The SHELTER Trial of Transplanting Donor Hepatitis C Virus RNA+ Lungs Into Uninfected Recipients

V. Potluri¹, P. Reese¹, S. Prenner¹, H. Mentch¹, D. Goldberg², T. Claridge¹, J. Smith¹, C. Gentile¹, V. Van Deerlin¹, R. Reddy¹, T. Fallah¹, C. Bermudez¹, M. Crespo¹, J. Diamond¹

Infectious Considerations for Lung Transplantation  •  Hynes Room 210

4:40pm-4:50pm

“ABO-Adjusted CPRA”: A Unified Metric for Immunologic Compatibility in Kidney Transplantation

L. Gragert¹, M. Kadatz², J. Alcorn³, D. Stewart³, D. Chang², J. Gill², R. Liwski⁴, H. Gebel⁵, E. Kransdorf⁶, J. Gill², J. Lan²

Kidney Deceased Donor Allocation  •  Hynes Ballroom C

4:40pm-4:50pm

130 Totally Robotic Donor Hepatectomy: Reproducibility Of A Standardized Technique Across 2 Specialized Centers

Y. Cheah¹, H. Yang², C. J. Simon¹, J. Kim³, M. Akoad³, G. Choi²

Late Breaking: Clinical  •  Hynes Room 313

4:40pm-4:50pm

Association of Native Kidney Disease with De Novo Cancer Development After Kidney Transplant

Y. Caliskan¹, D. Axelrod², R. Li¹, W. Cheungpasitporn³, M. Schnitzler¹, M. McAdams DeMarco⁴, J. Ahn⁴, T. Alhamad⁵, H. Randall¹, S. Bae⁴, D. Segev⁴, K. L. Lentine¹

PTLD and Malignancies  •  Hynes Room 309